HAO — Haoxi Health Technology Share Price
- $3.98m
- -$1.80m
- $48.52m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.35 | ||
Price to Tang. Book | 0.35 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.08 | ||
EV to EBITDA | -1.04 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 14.75% | ||
Return on Equity | 20.12% | ||
Operating Margin | 3.54% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | 12.85 | 16.16 | 28.23 | 48.52 | n/a | n/a | 55.73% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | -19.6 | +296.61 | +38.76 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- August 5th, 2022
- Public Since
- January 26th, 2024
- No. of Employees
- 30
- Sector
- Media & Publishing
- Industry
- Consumer Cyclicals
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 2,822,395

- Address
- BEIJING, 100101
- Web
- https://ir.haoximedia.com/
- Phone
- Auditors
- Wei, Wei & Co., LLP
Similar to HAO
Airnet Technology
NASDAQ Capital Market
Baosheng Media group
NASDAQ Capital Market
Beasley Broadcast
NASDAQ Capital Market
BloomZ
NASDAQ Capital Market
BUUU
NASDAQ Capital Market
FAQ
As of Today at 21:01 UTC, shares in Haoxi Health Technology are trading at $1.41. This share price information is delayed by 15 minutes.
Shares in Haoxi Health Technology last closed at $1.41 and the price had moved by -98.97% over the past 365 days. In terms of relative price strength the Haoxi Health Technology share price has underperformed the S&P500 Index by -99.05% over the past year.
There is no consensus recommendation for this security.
Find out moreHaoxi Health Technology does not currently pay a dividend.
Haoxi Health Technology does not currently pay a dividend.
Haoxi Health Technology does not currently pay a dividend.
To buy shares in Haoxi Health Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.41, shares in Haoxi Health Technology had a market capitalisation of $3.98m.
Here are the trading details for Haoxi Health Technology:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: HAO
Based on an overall assessment of its quality, value and momentum Haoxi Health Technology is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Haoxi Health Technology. Over the past six months, its share price has underperformed the S&P500 Index by -66.01%.
As of the last closing price of $1.41, shares in Haoxi Health Technology were trading -94.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Haoxi Health Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Haoxi Health Technology's directors